About the AI Drug Discovery Market Map
This market map tracks 88 startups across 8 categories in the AI Drug Discovery landscape. Target discovery, molecular design, protein folding, and clinical trial optimization accelerating the path from lab to patient. Curated by Hartmann Capital's venture research team, it provides a comprehensive view of the companies building in this space, from early-stage startups to growth-stage leaders.
Categories & Companies
Target Discovery & Validation(13)
Recursion (Public, $452M) · Insitro (Series C, $700M) · Verge Genomics (Series B, $100M) · Cellarity (Series C, $294M) · Valo Health (Series B, $460M) · Xaira Therapeutics (Series A, $1000M) · BenevolentAI (Public, $361M) · Enveda Biosciences (Series D, $400M) · Standigm (Pre-IPO, $71M) · Turbine AI (Series A, $38M) · Nimbus Therapeutics (Acquired, $637M) · Inductive Bio (Series A, $25M) · Spring Discovery (Series A, $16M)
Molecular Design & Generation(13)
Insilico Medicine (Series E, $400M) · Atomwise (Series C, $219M) · Genesis Therapeutics (Series B, $327M) · Iambic Therapeutics (Series B, $327M) · PostEra (Series A, $26M) · Iktos (Series A, $18M) · Entos (Series A, $54M) · Terray Therapeutics (Series B, $180M) · Charm Therapeutics (Series B, $150M) · Peptilogics (Series B2, $113M) · Relay Therapeutics (Public, $520M) · Proxima (VantAI) (Seed, $80M) · Menten AI (Seed, $4M)
Protein Structure & Engineering(13)
Isomorphic Labs (Seed, $600M) · Generate Biomedicines (Series C, $750M) · Absci (Public, $425M) · EvolutionaryScale (Seed, $142M) · Profluent (Series B, $150M) · Cradle (Series B, $103M) · Dyno Therapeutics (Series A, $109M) · Evozyne (Series B, $144M) · Arzeda (Series B, $33M) · Latent Labs (Series A, $50M) · Monod Bio (Seed, $25M) · Nabla Bio (Seed, $8M) · Adaptyv Bio (Series A, $20M)
Clinical Trial Optimization(13)
Unlearn.AI (Series C, $130M) · ConcertAI (Series C, $300M) · Saama Technologies (Growth, $75M) · Medable (Series D, $521M) · Deep 6 AI (Series A, $17M) · AiCure (Series B, $32M) · TrialSpark (Series B, $120M) · Antidote Technologies (Series A, $14M) · Medidata (Dassault) (Acquired) · Clinerion (Growth, $10M) · BioPhy (Seed) · Huma (Series D, $300M) · H1 (Series C, $100M)
ADMET & Toxicity Prediction(11)
Simulations Plus (Public) · Certara (Public) · Schrödinger (Public, $162M) · Cyclica (Acquired, $23M) · Collaborations Pharma (Seed, $5M) · molab.ai (Seed) · CarbonSilicon AI (Series A, $10M) · Cortex Discovery (Seed) · XtalPi (Series D, $785M) · Optibrium (Growth, $15M) · Lhasa Limited (Non-Profit)
Drug Repurposing(11)
Healx (Series C, $80M) · BioXcel Therapeutics (Public, $60M) · Lantern Pharma (Public, $26M) · NuMedii (Series A, $6M) · twoXAR (Series A, $10M) · Aria Pharmaceuticals (Series A, $20M) · OpenTargets (Non-Profit) · Barinthus Bio (Series A, $25M) · Pharnext (Public, $147M) · Plex Research (Seed) · CytoReason (Series C, $80M)
Biomarker Discovery(13)
Tempus AI (Public, $2300M) · Freenome (Series D, $1350M) · Owkin (Series B, $304M) · Grail (Acquired, $2000M) · SOPHiA Genetics (Public, $265M) · PathAI (Series C, $255M) · Veracyte (Public) · Flagship AION Labs (Growth, $60M) · Nference (Series C, $153M) · Promise Bio (Seed, $8M) · NeuroKaire (Series A, $10M) · Aignostics (Series A, $34M) · Foundation Medicine (Acquired)
AI Pharma Platforms(1)
Exscientia (Acquired, $682M)
Frequently Asked Questions
- What is the AI Drug Discovery market map?
- The AI Drug Discovery market map is a curated overview of 88 startups across 8 categories : Target Discovery & Validation, Molecular Design & Generation, Protein Structure & Engineering, Clinical Trial Optimization, ADMET & Toxicity Prediction, Drug Repurposing, Biomarker Discovery, AI Pharma Platforms. Target discovery, molecular design, protein folding, and clinical trial optimization accelerating the path from lab to patient. It is maintained by Hartmann Capital's venture research team.
- How many startups are tracked?
- This map currently tracks 88 startups across 8 categories: Target Discovery & Validation (13 companies), Molecular Design & Generation (13 companies), Protein Structure & Engineering (13 companies), Clinical Trial Optimization (13 companies), ADMET & Toxicity Prediction (11 companies), Drug Repurposing (11 companies), Biomarker Discovery (13 companies), AI Pharma Platforms (1 companies).
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.
- How often is this map updated?
- The AI Drug Discovery market map is updated on a rolling basis as new startups emerge, companies raise funding rounds, or the competitive landscape shifts.